Chieron Active Ingredients Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their notable products is OLMESARTAN MEDOXOMIL-ROUTE A, with a corresponding US DMF Number 33352.
Remarkably, this DMF maintains an Active status since its submission on October 08, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 05, 2021, and payment made on February 04, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II